Effects of SUlodexide on damaged endothelial Glycocalyx in pAtients with diabetes Mellitus type two: Reversing damage

Trial Profile

Effects of SUlodexide on damaged endothelial Glycocalyx in pAtients with diabetes Mellitus type two: Reversing damage

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 16 Sep 2011

At a glance

  • Drugs Sulodexide (Primary)
  • Indications Diabetic nephropathies; Embolism and thrombosis; Proteinuria; Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Acronyms SUGAR
  • Most Recent Events

    • 19 Jan 2010 Status changed from recruiting to active, no longer recruiting as reported by Netherlands Trial Register.
    • 04 Jan 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top